These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 9372869)
21. Near-infrared fluorescence labeled anti-TAG-72 monoclonal antibodies for tumor imaging in colorectal cancer xenograft mice. Zou P; Xu S; Povoski SP; Wang A; Johnson MA; Martin EW; Subramaniam V; Xu R; Sun D Mol Pharm; 2009; 6(2):428-40. PubMed ID: 19718796 [TBL] [Abstract][Full Text] [Related]
22. Improved radioimmunotherapeutic efficacy of an anticarcinoma monoclonal antibody (131I-CC49) when given in combination with gamma-interferon. Greiner JW; Ullmann CD; Nieroda C; Qi CF; Eggensperger D; Shimada S; Steinberg SM; Schlom J Cancer Res; 1993 Feb; 53(3):600-8. PubMed ID: 8425194 [TBL] [Abstract][Full Text] [Related]
23. Monoclonal antibody identification and characterization of a Mr 43,000 membrane glycoprotein associated with human breast cancer. Edwards DP; Grzyb KT; Dressler LG; Mansel RE; Zava DT; Sledge GW; McGuire WL Cancer Res; 1986 Mar; 46(3):1306-17. PubMed ID: 3510721 [TBL] [Abstract][Full Text] [Related]
24. VIL-A1, a monoclonal antibody reactive with common acute lymphatic leukemia cells. Knapp W; Majdic O; Bettelheim P; Liszka K Leuk Res; 1982; 6(2):137-47. PubMed ID: 6193374 [TBL] [Abstract][Full Text] [Related]
25. Antigens associated with multidrug resistance in H69AR, a small cell lung cancer cell line. Mirski SE; Cole SP Cancer Res; 1989 Oct; 49(20):5719-24. PubMed ID: 2571409 [TBL] [Abstract][Full Text] [Related]
26. Human T lymphocytes and hematopoietic cell lines express CD24-associated carbohydrate epitopes in the absence of CD24 mRNA or protein. Williams LA; Hock BD; Hart DN Blood; 1996 Oct; 88(8):3048-55. PubMed ID: 8874203 [TBL] [Abstract][Full Text] [Related]
27. Characterization of the colorectal carcinoma-associated antigen defined by monoclonal antibody D612. Fernsten PD; Primus FJ; Greiner JW; Simpson JF; Schlom J Cancer Res; 1991 Feb; 51(3):926-34. PubMed ID: 1988133 [TBL] [Abstract][Full Text] [Related]
28. Characterization and distribution in human tissues of a glycoproteic antigen defined by monoclonal antibody 1BE12 raised against the human breast cancer cell line T47D. Pancino G; Charpin C; Osinaga E; Betaille B; Le Roy M; Calvo F; Roseto A Cancer Res; 1990 Nov; 50(22):7333-42. PubMed ID: 2224861 [TBL] [Abstract][Full Text] [Related]
29. Minimizing immunogenicity of the SDR-grafted humanized antibody CC49 by genetic manipulation of the framework residues. Gonzales NR; Padlan EA; De Pascalis R; Schuck P; Schlom J; Kashmiri SV Mol Immunol; 2003 Oct; 40(6):337-49. PubMed ID: 14522015 [TBL] [Abstract][Full Text] [Related]
30. Combined immunohistochemical and autoradiographic analyses of antigen/antibody interactions in tumor xenograft models. DePalatis LR; Johnson KA; Kaplan DA Lab Invest; 1991 Jul; 65(1):111-20. PubMed ID: 2072661 [TBL] [Abstract][Full Text] [Related]
31. Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells. Jerome KR; Barnd DL; Bendt KM; Boyer CM; Taylor-Papadimitriou J; McKenzie IF; Bast RC; Finn OJ Cancer Res; 1991 Jun; 51(11):2908-16. PubMed ID: 1709586 [TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics and biodistribution of engineered single-chain antibody constructs of MAb CC49 in colon carcinoma xenografts. Pavlinkova G; Beresford GW; Booth BJ; Batra SK; Colcher D J Nucl Med; 1999 Sep; 40(9):1536-46. PubMed ID: 10492377 [TBL] [Abstract][Full Text] [Related]
33. Antiidiotypic response against murine monoclonal antibodies reactive with tumor-associated antigen TAG-72. Blanco I; Kawatsu R; Harrison K; Leichner P; Augustine S; Baranowska-Kortylewicz J; Tempero M; Colcher D J Clin Immunol; 1997 Jan; 17(1):96-106. PubMed ID: 9049790 [TBL] [Abstract][Full Text] [Related]
34. Specificity analysis of murine monoclonal antibodies reactive with Tn, sialylated Tn, T, and monosialylated (2-->6) T antigens. O'Boyle KP; Markowitz AL; Khorshidi M; Lalezari P; Longenecker BM; Lloyd KO; Welt S; Wright KE Hybridoma; 1996 Dec; 15(6):401-8. PubMed ID: 8985750 [TBL] [Abstract][Full Text] [Related]
35. Development of oligoclonal nanobodies for targeting the tumor-associated glycoprotein 72 antigen. Sharifzadeh Z; Rahbarizadeh F; Shokrgozar MA; Ahmadvand D; Mahboudi F; Rahimi Jamnani F; Aghaee Bakhtiari SH Mol Biotechnol; 2013 Jun; 54(2):590-601. PubMed ID: 23015323 [TBL] [Abstract][Full Text] [Related]
37. A CDR-grafted (humanized) domain-deleted antitumor antibody. Slavin-Chiorini DC; Kashmiri SV; Lee HS; Milenic DE; Poole DJ; Bernon E; Schlom J; Hand PH Cancer Biother Radiopharm; 1997 Oct; 12(5):305-16. PubMed ID: 10851481 [TBL] [Abstract][Full Text] [Related]
38. Clinical and immunologic effects of monoclonal antibody CC49 and interleukin-2 in patients with metastatic colorectal cancer. Triozzi PL; Kim JA; Martin EW; Colcher D; Heffelfinger M; Rucker R Hybridoma; 1997 Apr; 16(2):147-51. PubMed ID: 9145316 [TBL] [Abstract][Full Text] [Related]
39. Analysis of two human monoclonal antibodies against melanoma. Yeilding NM; Gerstner C; Kirkwood JM Int J Cancer; 1992 Dec; 52(6):967-73. PubMed ID: 1459738 [TBL] [Abstract][Full Text] [Related]
40. Production of mouse monoclonal anti-idiotypic antibodies specific to epitopes of tumor-associated mucin TAG-12. Schmitt H; Khazaeli MB; Rodenburg CM; Kaul S; Bastert G Hybridoma; 1994 Oct; 13(5):389-96. PubMed ID: 7532153 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]